Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system. 

Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system.

In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc.

Visit us at www.abbottvascular.com for current information about the company.

Biotechnology

Health Care

Medical Devices

Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.]

Ferolyn Powell

Jan Komtebedde

Gloria Valencia

John Rasmusson

Meera Kottar

Tin Hoang

Misty Earley

The Manufacturing and Quality Assurance team at Evalve, Inc. is responsible for ensuring the seamless production of innovative cardiac valve repair devices, like the MitraClip® system. They focus on maintaining regulatory compliance, optimizing manufacturing processes, overseeing quality control, and conducting thorough inspections to guarantee that all products meet the highest safety and efficacy standards. Their collaborative efforts ensure the delivery of reliable and effective medical solutions to healthcare providers and patients.

Manufacturing and Quality Assurance

Leadership Team

Manufacturing and Quality Assurance

About

Team members

Other teams at Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.]

Leadership Team